INTRODUCTION {#sec1_1}
============

The genus *Aeromonas* comprises several species of oxidase-negative and catalase-positive, glucose-fermenting, facultative anaerobic, Gram-negative, rod-shaped, motile and non-motile bacteria ([@B1]). They are widely distributed in nature, especially in aquatic environments and have been isolated from various raw foods, such as fish and vegetables. These bacteria are widely found in surface water and sewage; they also occur in untreated and treated drinking-water ([@B2]). In humans, *Aeromonas* species are responsible for gastroenteritis, chronic diarrhoea, wound infections, respiratory tract infections, peritonitis, urinary tract infections, and septicaemia ([@B3]). *Aeromonas* spp. have been implicated as diarrhoea-causing agents in both HIV-positive and HIV-negative patients in South Africa ([@B4]). However, no study has determined the possible genetic relationship between environmental and clinical strains.

Genomic fingerprinting methods, such as random amplified polymorphic DNA PCR (RAPD) typing, are regarded as accurate methods for the typing of microorganisms for epidemiological purposes ([@B5]).

Although *Aeromonas* spp. have been described in South Africa, there is a paucity of studies that have determined the possible source of human infections, including the phylogenetic relatedness between clinical and environmental isolates. In the present study, RAPD was employed to determine the genetic relatedness of strains isolated from diarrhoeal stool and water specimens collected from water-storage containers from different geographical areas in the Limpopo province, South Africa.

MATERIALS AND METHODS {#sec1_2}
=====================

Study sites and ethical clearance {#sec1_2_1}
---------------------------------

Stool samples and household drinking-water samples were collected from HIV and AIDS patients in different locations in the Limpopo province, including Belabela, Madombidzha, Mankweng (Polokwane), and Musina. *Aeromonas* spp. were isolated from these samples and characterized as previously described ([@B6]). Thirty-two strains of *Aeromonas hydrophila* from these samples were used in the present study for beta-lactamase production, antibiotic susceptibility as previously described ([@B6]), and in genotyping studies. The geographical origins and sources of the strains used in the study are indicated in the [table](#T1){ref-type="table"}. Ethical clearance was obtained from the Ethics and Research Committee of the University of Venda, Thohoyandou, Limpopo province, South Africa.

Genomic DNA extraction {#sec1_2_2}
----------------------

Extraction of whole-cell DNA was performed by a precipitation-based method as described previously ([@B7]). Briefly, the cells were lysed by the addition of SDS (Promega, Madison, WI) and lysozyme (Sigma Chemical Co. St. Louis, MO, USA) with incubation at 37 °C (QBT2 heating block, Grant Instruments Ltd., Cambridge, United Kingdom) for one hour. The DNA was further isolated using chloroform/isoamyalcohol (24:1) (Sigma Chemical Co., St. Louis, MO, USA) and precipitated with isopropanol (Merck, Darmstadt, Germany) at −20 °C overnight and stored at −20 °C until further analysis.

Confirmation of *Aeromonas hydrophila* identity by 16S rRNA gene-sequencing {#sec1_2_3}
---------------------------------------------------------------------------

All the *Aeromonas* strains used in the present study were identified as previously described and confirmed by PCR analysis and sequencing of the 16S rRNA gene for two isolates. The 16S rRNA gene sequence was PCR-amplified in a Perkin-Elmer GeneAmp PCR System 2400 thermocycler as previously described ([@B5])

All DNA extractions and PCR products were verified by gel electrophoresis for one hour in a 1% agarose gel (Pronadisa, Madrid, Spain) containing ethidium bromide (Promega, Madison, WI, USA) and the images captured using a digital gel documentation system (DigiDoc-It imaging system, UVP, Upland, CA, USA).

Random amplified polymorphic DNA analysis of strains {#sec1_2_4}
----------------------------------------------------

Random amplified polymorphic DNA analysis was performed on 32 isolates using whole-cell DNA as template to determine the genetic relationships of isolates according to a modified method previously described ([@B8], [@B9]) using three different primers to obtain a banding pattern representative of the whole genome. All the samples were run at least twice using each primer.

Analysis of RAPD fingerprints {#sec1_2_5}
-----------------------------

The amplification products were electrophoresed in 1.5% agarose gel in Tris-borate buffer. Computer analyses were carried out using the GelCompar II software (version 3.0; Applied Maths, Kortrijk, Belgium). Similarity between fingerprints was calculated with the Dice coefficient. Cluster analysis was performed using the unweighted pair-group method with average linkages (UPGMA).

RESULTS {#sec1_3}
=======

The fingerprints of the isolates generated between 2 and 17 bands ranging from 100 to 3,500 bp. The banding patterns proved reproducible when repeated on two separate occasions. Random amplified polymorphic DNA fingerprints which possessed more than 90% similarity were considered identical and were assigned an RAPD type. On this basis, 12 unique RAPD types were assigned as shown in the [figure](#F1){ref-type="fig"}. The isolates and the specimen types from which the isolates were obtained are shown in the [table](#T1){ref-type="table"}.

There was a difference between the clinical and the environmental strains. Type 1, for example, was composed of four clinical strains, and type 4 was composed of five clinical strains while type 7 was composed of all four environmental strains. However, there was a mixture of clinical and environmental strains in the same type.

DISCUSSION {#sec1_4}
==========

We had previously isolated and characterized *Aeromonas* spp. from stool and water samples from different areas in the Limpopo province ([@B6]). However, previous studies were not able to fully ascribe any genetic relatedness between the environmental and the clinical isolates. In the present study, three primers were used for RAPD fingerprinting of 32 *A. hydrophila* strains from stools and water samples from HIV and AIDS patients from five different localities approximately 400 km apart throughout the Limpopo province situated in the northern part of South Africa.

###### 

Characteristics and random amplified polymorphic types of *Aeromonas hydrophila* strains used in the present study

  Locality      Isolate[\*](#TF1-001){ref-type="table-fn"}   RAPD type   Beta-lactamase production   Antibiotic resistance combination
  ------------- -------------------------------------------- ----------- --------------------------- -------------------------------------------------------------------------
  Belabela      6165S                                        1           Negative                    Ampicillin
  Belabela      6168S                                        1           Negative                    Ampicillin
  Belabela      6173S                                        4           Negative                    Amikacin, ampicillin, cefotaxime, nitrofurantoin, tobramycin
  Belabela      6197S                                        4           Positive                    Amikacin, ampicillin, cefazolin, cefotaxime
  Belabela      6237S                                        5           Positive                    Ampicillin, cefotaxime, nitrofurantoin, tobramycin
  Belabela      6164E                                        5           Negative                    Ceftriaxone, ciprofloxacin, gentamicin, ampicillin
  Belabela      6249E                                        6           Positive                    Amikacin, ampicillin, cefazolin, cefotaxime, nitrofurantoin, tobramycin
  Belabela      6241E                                        7           Negative                    Nitrofurantoin, amikacin, ampicillin
  Belabela      6238S                                        12          Negative                    Nitrofurantoin
  Belabela      6248E                                        11          Negative                    Ampicillin
  Madombidhza   6171S                                        1           Negative                    Ampicillin
  Madombidhza   6170S                                        4           Negative                    Ampicillin, nitrofurantoin, tobramycin
  Madombidhza   6199S                                        6           Positive                    Ampicillin, cefazolin, nitrofurantoin, tobramycin
  Madombidhza   6250E                                        7           Negative                    Ampicillin
  Madombidhza   6183S                                        10          Negative                    Ampicillin, cefazolin, ampicillin
  Madombidhza   6184S                                        11          Negative                    Ampicillin
  Mankweng      6242E                                        8           Negative                    Amikacin, ampicillin, cefazolin, cefotaxime, nitrofurantoin, tobramycin
  Mankweng      6258E                                        7           Negative                    Ampicillin
  Mankweng      6166S                                        1           Negative                    Ampicillin
  Mankweng      6189E                                        6           Negative                    Tobramycin
  Mankweng      6182S                                        5           Negative                    Ampicillin
  Mankweng      6255E                                        11          Negative                    Nitrofurantoin, tobramycin
  Mankweng      6172S                                        11          Negative                    Amikacin, ampicillin, cefazolin, cefotaxime, nitrofurantoin, tobramycin
  Musina        6257E                                        2           Negative                    Nitrofurantoin
  Musina        6175S                                        4           Negative                    Ampicillin, cefazolin
  Musina        6174S                                        3           Negative                    Amikacin, ampicillin, cefazolin, cefotaxime, nitrofurantoin, tobramycin
  Musina        6239E                                        5           Negative                    Ampicillin
  Musina        6192E                                        5           Negative                    Ampicillin
  Musina        6190E                                        6           Negative                    Ampicillin
  Musina        6240E                                        7           Negative                    Ampicillin
  Musina        6247E                                        9           Negative                    Tobramycin
  Musina        6198S                                        4           Negative                    Amikacin, ampicillin, cefazolin, cefotaxime, nitrofurantoin, tobramycin

\*At the end of the code: E=Environmental (water samples);

S=Stool

The banding patterns obtained in the present study were similar to those obtained by other researchers ([@B5]).

The results indicate a high genetic diversity in the *A. hydrophila* population in South Africa even though there was a mixture of environmental and clinical strains in some RAPD types probably due to separate introductions of the strains in the localities and poor health practices ([@B10], [@B11]). Other studies around the world, using genetic methods, have described high diversity in the *A. hydrophila* population ([@B12], [@B13]). Previous studies have indicated that homologs of a gene encoding a protein with lipase activity appeared to be widely distributed in *Aeromonas* strains, probably associating with the evolutionary genetic difference between clinical and environmental isolates of *A. hydrophila* ([@B14]). We have previously shown that clinical strains of *A. hydrophila* possessed pathogenic characteristics, such as haemolytic and haemagglutinating activities ([@B6]). It is, thus, possible that the environmental strains that had similar RAPD profiles as clinical strains might share pathogenic characteristics as well. Studies of *A. hydrophila* in Japan, using randomly-amplified polymorphic DNA-PCR (RAPD-PCR), revealed one specific RAPD pattern group (G) that was associated only with strains from environmental sources. The comparison of isolates with pattern group G with a set of isolates derived from human blood showed low induction of cytotoxicity from those with RAPD pattern group G suggesting low virulence of these strains ([@B13]).

Although antibiotic resistance was common, statistical analysis using the chi-square test indicated that RAPD type 4 was more associated with amikacin resistance (χ^2^=3.872; p=0.049) and resistance to cefotaxime (χ^2^=3.872; p=0.049). Of all the strains tested, four were beta-lactamase-positive, of which two were of RAPD type 6. Statistical analysis indicated that RAPD type 6 was more associated with beta-lactamase production (χ^2^=5.878, p=0.015). Multiple drug resistance (MDR) defined as resistance of a specific strain to more than two antibiotics was common (41%) among the strains tested. Statistical analysis indicated that RAPD type 4 was more associated with MDR (χ^2^=4.567, p=0.033). In a previous study, there was a correlation between the antibiotic resistance profile and the RAPD profiles of specific *Aeromonas* isolates ([@B15]).

In the present study, we did not find a clear differentiation between strains from different localities. RAPD type 1 was not found in Musina area but was found in all the other areas, including Belabela, Mankweng, and Madombidzha. Some RAPD genotypes included only one strain ([Fig.](#F1){ref-type="fig"}). For example, RAPD genotype 2, type 3, and type 9 were all obtained from Musina area and included the environmental and clinical isolates while type 8, 10, and 12 were obtained from Mankweng, Madombidzha, and Belabela respectively. This diversity indicates the need for regular monitoring of *Aeromonas* strains for pathogenic characteristics and for the possibility of epidemic strains that could be circulating in the population. Studies of clinical and environmental ecotypes of *Aeromonas* in Mexico demonstrated the high intra-specific diversity within *A. hydrophila* and revealed a clear differentiation of strains according to their ecological origins ([@B16]). The same study also confirmed, based on the distribution of virulence-related genes, that *A. hydrophila* is a genetically-heterogeneous species that harbour ecotypes which have different pathogenic potentials to humans and other animals.

![Dendogram obtained through RAPD typing with primer 277, H1, and 275 depicting the relationship between *Aeromonams hydrophila* stool isolates and water isolates obtained from Limpopo](jhpn0028-0001_f01){#F1}

The results indicating the genetic similarity between the clinical and the environmental isolates of *A. hydrophila* in this study do not accord with those obtained in Switzerland that showed no genetic relationship between clinical and environmental strains ([@B17]). Studies in France also found that the water sampled in the hospital was not the source of infections for patients at the University Hospital in Marseille ([@B18]). With the high prevalence of HIV and AIDS in South Africa, patients might become more susceptible to infection by *Aeromonas,* and the possibility of acquiring the organisms from water is high and represents a great threat to human health. The results of the present study have revealed the possibility of an intricate web of relationship between isolates from stool and water samples in the Limpopo province of South Africa, indicating cross-contaminations and points to the need for effective control measures. The present study also showed that specific genotypes might be related to antibiotic resistance. Further studies on the cytotoxicity of strains under investigation are warranted and will further clarify the pathogenic characteristics of *A. hydrophila* strains in the region.
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